InsidersTradesSigma
Follow the 亿帆医药 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 亿帆医药 has recorded 1 reports. Market capitalisation: €12.5bn. The latest transaction was reported on 8 February 2024 (Purchase). Among the most active insiders: 李锡明. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
亿帆医药 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and manufacturing of innovative drugs.